TY - JOUR AU - Schleidgen, Sebastian AU - Dederer, Hans-Georg AU - Sgodda, Susan AU - Cravcisin, Stefan AU - Lüneburg, Luca AU - Cantz, Tobias AU - Heinemann, Thomas PY - 2020 DA - 2020/09/11 TI - Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy JO - BMC Medical Ethics SP - 87 VL - 21 IS - 1 AB - Clustered Regularly Interspaced Short Palindromic Repeats-associated (CRISPR-Cas) technology may allow for efficient and highly targeted gene editing in single-cell embryos. This possibility brings human germline editing into the focus of ethical and legal debates again. SN - 1472-6939 UR - https://doi.org/10.1186/s12910-020-00487-1 DO - 10.1186/s12910-020-00487-1 ID - Schleidgen2020 ER -